🔍Diagnostics & Precision Medicine
Molecular diagnostics, companion diagnostics, and precision medicine tools for disease detection and treatment selection.
Market Cap$960.6B
1D-1.64%
Companies2,262
Public Cos143
SECTOR MARKET CAP
$960.6B+26113.6%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | Switzerland | $219.3B | ROG.SW |
| 2 |  | Ireland | $149.2B | ABT |
| 3 |  | Ireland | $98.7B | MDT |
| 4 |  | United States | $53.9B | AME |
| 5 |  | Germany | $44.4B | SHL.DE |
| 6 |  | United States | $42.7B | BDX |
| 7 |  | United States | $32.3B | A |
| 8 |  | United States | $29.0B | NTRA |
| 9 |  | United States | $23.4B | DXCM |
| 10 |  | United States | $20.8B | LH |
| 11 |  | United States | $20.5B | ILMN |
| 12 |  | United States | $12.6B | GH |
| 13 |  | United States | $12.1B | MEDP |
| 14 |  | United States | $11.8B | COO |
| 15 |  | United Kingdom | $11.5B | ORNBV.HE |
| 16 |  | United States | $11.1B | 7733.T |
| 17 |  | United States | $10.9B | RVTY |
| 18 |  | France | $9.9B | BIM.PA |
| 19 |  | China | $9.7B | 600196.SS |
| 20 |  | United States | $9.3B | MASI |